Development of Lipomer Nanoparticles for the Enhancement of <i>Drug</i> Release, Anti-Microbial Activity and Bioavailability of Delafloxacin

• Главные авторы: Md. Khalid Anwer (Автор), Muzaffar Iqbal (Автор), Magdy M. Muharram (Автор), Muqtader Mohammad (Автор), Essam Ezzeldin (Автор), Mohammed F. Aldawsari (Автор), Ahmed Alalaiwe (Автор), Faisal Imam (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2020-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Delafloxacin (DFL) is a novel potent and broad-spectrum fluoroquinolone group of antibiotics effective against both Gram-positive and negative aerobic and anaerobic bacteria. In this study, DFL-loaded stearic acid (lipid) chitosan (polymer) hybrid nanoparticles (L-P-NPs) have been developed by singl...